Botanical species · safety record

Caesalpinia pulcherrima

The EFSA Compendium of Botanicals holds 7 constituent measurements and 2 adverse-effect records for Caesalpinia pulcherrima. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Caesalpinia pulcherrima (L.) Sw.

7Constituent measurements

2Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Cardiac glycosides	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Coumarins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Ellagitannins (hydrolysable tannins)	Bark	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Myrcene	Leaves	Essential oil	5.6 Percent	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Endocrine	Uterus	Leaves	Solvent extraction	House mouse (as animal)	Reproduction toxicity	Resolve DOI
Endocrine	Uterus	Leaves	Solvent extraction	House mouse (as animal)	Reproduction toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sivasankari, K., Janaky, S., Sekar, T. Evaluation of phytochemicals in select medicinal plants of the Caesalpinia species. Indian journal of science and technology, 2010, vol. 3, no. 12, p. 1118-1121. DOI
AWASTHI, KK., KUMAR, A., MISRA, K. A NEW TANNIN FROM YOUNG STEM BARK OF CAESALPINIA-PULCHERRIMA. CURRENT SCIENCE, 1980, vol. 49, no. 20, p. 769-772.
Kumar, S., Singh, J., Baghotia, A., Mehta, V., Thakur, V., Choudhary, M., Verma, S., Kumar, D. Antifertility potential of the ethanolic extract of Caesalpinia pulcherrima Linn. leaves. Asian pacific journal of reproduction, 2013, vol. 2, no. 2, p. 90-92. DOI
Usman, L. A., Zubair, M. F., Olawore, N. O., Ashamu, M., Ismaeel, R. O., Oladosu, I. A. Chemical constituents of leaf essential oils of two varieties of Caesalpinia pulcherrima Linn growing in north central Nigeria. Elixir online journal, 2012, p. 7085-7087.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature